| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 06/15/2006 | WO2004087887A3 Intracellular complexes as biomarkers |
| 06/15/2006 | WO2004081182A3 Compositions and methods for polynucleotide sequence detection |
| 06/15/2006 | US20060130185 Plant transformation and selection |
| 06/15/2006 | US20060129043 System for and method of positioning cells and determing cellular activity thereof |
| 06/15/2006 | US20060127980 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 06/15/2006 | US20060127907 Method of detecting gene mutation |
| 06/15/2006 | US20060127905 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase |
| 06/14/2006 | EP1668361A2 Cell-based assays for determining drug action |
| 06/14/2006 | EP1668157A2 Hairpin-labeled probes and methods of use |
| 06/14/2006 | EP1668134A2 Broad host range pbbr1-based plasmid mutant derivatives having altered plasmid copy number |
| 06/14/2006 | EP1668114A2 Polypeptide display libraries and methods of making and using thereof |
| 06/14/2006 | EP1668112A2 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and essays for making and using |
| 06/14/2006 | EP1668111A2 Osteoarthritis biomarkers and uses thereof |
| 06/14/2006 | EP1668110A2 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders |
| 06/14/2006 | EP1668067A2 Crosslinking within coordination complexes |
| 06/14/2006 | EP1667714A2 Consensus/ancestral immunogens |
| 06/14/2006 | EP1667522A2 Modified oligonucleotides for telomerase inhibition |
| 06/14/2006 | EP1667521A2 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency |
| 06/14/2006 | EP1667520A2 Methods for improving growth and crop productivity of plants by adjusting plant hormone levels, ratios and/or co-factors |
| 06/14/2006 | EP1667513A2 Improvements in grass endophytes |
| 06/14/2006 | CN1788014A Nucleotide sequences regulating gene expression and constructs and methods utilizing same |
| 06/13/2006 | US7060501 contacting a cell containing a polynucleotide with an organophosphate and detecting whether or not hydrolysis has occured; extraction of the hydrolysis product from the cell is not necessary to detect the hydrolysis; the conditions that do not require destruction of the cell. |
| 06/13/2006 | US7060490 having an N-terminal domain, a DNA-binding domain and a ligand-binding domain |
| 06/13/2006 | US7060278 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 06/08/2006 | WO2005056753A3 Methods of determining juvenile arthritis classification |
| 06/08/2006 | WO2005052121A3 Multivalent aptamers |
| 06/08/2006 | WO2005052120A3 Apparatus and methods for assessing metabolic substrate utilization |
| 06/08/2006 | WO2005047487B1 Motoneuronotrophic factor gene sequences |
| 06/08/2006 | WO2005035724A3 Cancer-linked genes as targets for chemotherapy |
| 06/08/2006 | WO2005028629A3 Whole genome expression analysis system |
| 06/08/2006 | WO2005023991A3 Small hairpin rna libraries |
| 06/08/2006 | WO2005007810A3 Functional synthetic molecules and macromolecules for gene delivery |
| 06/08/2006 | US20060122379 Method of alpha-selective glycosylation |
| 06/08/2006 | US20060121519 Ligand and coordinating moiety for isolating preferential macromolecules in solution |
| 06/08/2006 | US20060121463 Allelic variation in human gene expression |
| 06/08/2006 | US20060121459 Receptors and membrane-associated proteins |
| 06/08/2006 | US20060121441 Methods of determining the effect of an agent on diploid cells and/or on the pattern of expression of polypeptides expressed therewith |
| 06/08/2006 | US20060121085 Formulations for cell-schedule dependent anticancer agents |
| 06/07/2006 | EP1666604A1 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 06/07/2006 | EP1666048A2 Method for producing insulin from a natural source and insulin |
| 06/07/2006 | EP1664343A2 Methods and compositions for generation of germline human antibody genes |
| 06/07/2006 | EP1664321A2 Methods for expression and purification of immunotoxins |
| 06/07/2006 | EP1664320A2 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 06/07/2006 | EP1664288A2 Mylks as modifiers of branching morphogenesis and methods of use |
| 06/07/2006 | EP1664283A2 Cell culture media |
| 06/07/2006 | EP1664275A2 In vivo synthesis of connective tissues |
| 06/07/2006 | EP1664274A2 Silencing of tgf-beta receptor type ii expression by sirna |
| 06/07/2006 | EP1664273A2 Arrays, methods and kits for preparation and use of syntenic genomic arrays for diagnostics and toxicology |
| 06/07/2006 | EP1664272A2 Targeting endothelium for tissue-specific delivery of agents |
| 06/07/2006 | EP1664268A2 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection |
| 06/07/2006 | EP1664267A2 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 06/07/2006 | EP1663303A2 Immunogenic compositions for streptococcus agalactiae |
| 06/07/2006 | EP1663275A2 Stationary phases and a purification process using the stationary phases |
| 06/07/2006 | EP1441591A4 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response |
| 06/07/2006 | CN1784600A Chromatographic assay system |
| 06/07/2006 | CN1784488A Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines |
| 06/07/2006 | CN1784184A Photomodulation methods and devices for regulating cell proliferation and gene expression |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/06/2006 | US7057031 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 06/06/2006 | US7056704 RNA interference mediating small RNA molecules |
| 06/06/2006 | US7056673 Preservation of RNA in a biological sample |
| 06/01/2006 | WO2005047478A3 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 06/01/2006 | WO2005028616A3 Morphogen compositions and methods of use thereof to treat heart disorders |
| 06/01/2006 | WO2005019426A3 Gene cluster for fostriecin biosynthesis |
| 06/01/2006 | WO2005017123A3 Mptens as modifiers of the pten pathway and methods of use |
| 06/01/2006 | WO2005012492A8 Human skin equivalents expressing exogenous polypeptides |
| 06/01/2006 | WO2005001025A3 Immunoglobulin chimeric monomer-dimer hybrids |
| 06/01/2006 | WO2004108896A3 Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors |
| 06/01/2006 | WO2004085617B1 TIMP3 as VEGF inhibitor |
| 06/01/2006 | US20060117413 generating transgenic plantS comprising introducing into a somatic embryo, a polynucleotide encoding dihydrodipicolinate synthase (DHPS) polypeptide, effective to render the embryo resistant to S-2-aminoethylcysteine; herbicide resistance |
| 05/31/2006 | EP1660687A2 Rnai-based modification of heterochromatin |
| 05/31/2006 | EP1660685A2 Antisense inhibition of laminin-8 expression to inhibit human gliomas |
| 05/31/2006 | EP1660678A2 Mutant adeno-associated virus virions and methods of use thereof |
| 05/31/2006 | EP1660660A2 Polypeptides of streptococcus pyogenes |
| 05/31/2006 | EP1660653A2 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells |
| 05/31/2006 | EP1660646A2 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 05/31/2006 | EP1660638A2 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/31/2006 | EP1660636A2 Anti-cancer vaccines |
| 05/31/2006 | EP1660635A2 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders |
| 05/31/2006 | EP1660634A2 P16 mediated regulation of nmda receptors |
| 05/31/2006 | EP1660632A2 Human skin equivalents expressing exogenous polypeptides |
| 05/31/2006 | EP1660631A2 Compositions and methods for preparing short rna molecules and other nucleic acids |
| 05/31/2006 | EP1660629A2 Automated cell culture system and process |
| 05/31/2006 | EP1660628A2 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF |
| 05/31/2006 | EP1660514A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis |
| 05/31/2006 | EP1660184A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 05/31/2006 | EP1660094A2 Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections |
| 05/31/2006 | EP1659996A2 Citrus sesquiterpene synthase, methods of production and uses thereof |
| 05/31/2006 | EP1592806A4 Methos for analyzing global regulation of coding and non-coding rna transcripts involving low molecular weight rnas |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | CN1780920A Gene expression suppression agents |
| 05/31/2006 | CN1780912A Method for inhibiting cell growth and composition therefor |
| 05/31/2006 | CN1780851A Method and carrier complexes for delivering molecules to cells |
| 05/31/2006 | CN1780641A Single chain antigen-binding polypeptides for polymer conjugation |
| 05/31/2006 | CN1780640A Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 05/31/2006 | CN1780560A Method for producing ethanol using raw starch |
| 05/31/2006 | CN1780554A Clinically relevant animal model of human breast cancer and VEGF involvement in desmoplastic response, tamoxifen resistance and metastasis |
| 05/30/2006 | US7052698 Surface proteins of Leptospira |